I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

Nasal drug delivery is advantageous when compared with other routes of drug delivery as it
avoids the hepatic first-pass effect, blood–brain barrier penetration, and compliance issues …

A recommended first-line acute bacterial rhinosinusitis (ABR) treatment regimen includes a
high dose of orally administered amoxicillin, despite its frequent systemic adverse reactions …

The coronavirus disease 2019 (COVID-19) pandemic has ignited interest in viral
transmission and prevention owing to the significant morbidity and mortality associated with …

The unprecedented situation of the COVID-19 pandemic heavily polluted water bodies
whereas the presence of SARS-CoV-2, even in treated wastewater in every corner of the …

Background: COVID-19 is an asymptomatic condition in 40% of cases, and most
symptomatic patients present with mild/moderate disease not requiring hospitalization or …

Abstract The Korean Society of Otorhinolaryngology-Head and Neck Surgery and Korean
Rhinologic Society appointed a guideline development group (GDG) to establish a clinical …

Objective To provide a state of the art review of intranasal antiviral drug delivery and to
discuss current applications, adverse reactions, and future considerations in the …

The history of saline nasal irrigation (SNI) is indeed a long one, beginning from the ancient
Ayurvedic practices and gaining a foothold in the west at the beginning of the 20th century …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the start of the …